Genomic Valley Biotech Ltd.
Genomic Valley
₹ 0.00
0.00 (0.00)%
NSE
BSE
Agri
Small-cap - With a market cap of ₹7.41 Cr.
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | Audited Results & Quarterly Results |
| 10 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results |
| 28 05 2022 | Quarterly Results & Audited Results |
| 20 07 2022 | Quarterly Results |
| 12 11 2022 | Quarterly Results |
| 10 02 2023 | Quarterly Results |
| 29 05 2023 | Quarterly Results & Audited Results |
| 14 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 14 11 2023 | Quarterly Results (Revised) |
| 10 02 2024 | Quarterly Results |
| 14 02 2024 | Quarterly Results (Revised) |
| 07 10 2024 | Quarterly Results |
| 06 12 2024 | Inter alia, to consider the following items: a) To consider and Approve the Director?s Report of the Board of Director of the company for the Financial Year 2023-24. b) To Consider and Approve the date, time, venue and mode for convening the 30th Annual General Meeting of the Company. c) To consider and approve to appoint SBR & Co. LLP, Company Secretaries, as Scrutinizer for the ensuing Annual General Meeting. d) To consider any other business with the permission of the chair |
| 14 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results & Quarterly Results |
| 07 08 2025 | Quarterly Results |
| 15 10 2025 | Quarterly Results |
| 15 01 2026 | Quarterly Results |
No News data available
